A twenty-year journey exploring coumarin-based derivatives as bioactive molecules.
cancer
cholinesterases
coumarin
monoamine oxidases
neurodegeneration
Journal
Frontiers in chemistry
ISSN: 2296-2646
Titre abrégé: Front Chem
Pays: Switzerland
ID NLM: 101627988
Informations de publication
Date de publication:
2022
2022
Historique:
received:
25
07
2022
accepted:
14
09
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
28
10
2022
Statut:
epublish
Résumé
The coumarin core (i.e., 1-benzopyran-2 (2
Identifiants
pubmed: 36300022
doi: 10.3389/fchem.2022.1002547
pii: 1002547
pmc: PMC9590106
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1002547Informations de copyright
Copyright © 2022 Pisani, Catto, Muncipinto, Nicolotti, Carrieri, Rullo, Stefanachi, Leonetti and Altomare.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Med Chem. 2009 Nov 12;52(21):6685-706
pubmed: 19810674
ChemMedChem. 2010 Sep 3;5(9):1616-30
pubmed: 20677317
Molecules. 2018 Jan 27;23(2):
pubmed: 29382051
Eur J Med Chem. 2015 Jan 7;89:106-14
pubmed: 25462231
J Med Chem. 1998 Sep 24;41(20):3812-20
pubmed: 9748356
J Med Chem. 2000 Dec 14;43(25):4747-58
pubmed: 11123983
Science. 1991 Aug 23;253(5022):872-9
pubmed: 1678899
Heliyon. 2021 Mar 16;7(3):e06255
pubmed: 33786386
Bioorg Med Chem. 2008 Aug 1;16(15):7450-6
pubmed: 18585045
J Med Chem. 2016 Jul 28;59(14):6791-806
pubmed: 27347731
J Med Chem. 2006 Aug 10;49(16):4912-25
pubmed: 16884303
J Med Chem. 2022 Mar 10;65(5):3962-3977
pubmed: 35195417
Chem Res Toxicol. 1992 May-Jun;5(3):366-75
pubmed: 1504260
Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12684-9
pubmed: 16129825
J Med Chem. 2011 Mar 24;54(6):1613-25
pubmed: 21341743
J Med Chem. 2001 Sep 13;44(19):3195-8
pubmed: 11543689
ChemMedChem. 2017 Aug 22;12(16):1349-1358
pubmed: 28570763
Bioorg Med Chem. 2013 Jan 1;21(1):146-52
pubmed: 23199476
Cancer Res. 2003 Mar 15;63(6):1214-20
pubmed: 12649179
Eur J Pharm Sci. 2017 Apr 1;101:90-99
pubmed: 28188911
J Med Chem. 2013 Mar 28;56(6):2651-64
pubmed: 23437843
Molecules. 2019 Dec 09;24(24):
pubmed: 31835376
Front Oncol. 2020 Dec 04;10:592853
pubmed: 33344242
J Med Chem. 2007 Nov 15;50(23):5848-52
pubmed: 17915852
Clin Cancer Res. 2006 Mar 1;12(5):1585-92
pubmed: 16533785
J Biol Chem. 2004 Nov 12;279(46):48071-8
pubmed: 15358790
J Med Chem. 2015 Jul 23;58(14):5561-78
pubmed: 26107513
Eur J Med Chem. 2015 Jan 7;89:98-105
pubmed: 25462230
ACS Med Chem Lett. 2020 Feb 07;11(5):869-876
pubmed: 32435398
Chem Biodivers. 2006 Feb;3(2):134-49
pubmed: 17193252
Eur J Med Chem. 2019 Jan 1;161:292-309
pubmed: 30366255
Neuron. 1996 Apr;16(4):881-91
pubmed: 8608006
Br J Pharmacol. 2006 Jan;147 Suppl 1:S287-96
pubmed: 16402116
Expert Rev Neurother. 2008 Nov;8(11):1703-18
pubmed: 18986241
J Med Chem. 2016 Jun 23;59(12):5721-39
pubmed: 27213819
Neurochem Int. 1992 Oct;21(3):381-96
pubmed: 1303164
Molecules. 2016 Mar 17;21(3):362
pubmed: 26999091
J Med Chem. 2004 Dec 30;47(27):6792-803
pubmed: 15615528
J Med Chem. 1995 Sep 15;38(19):3874-83
pubmed: 7562919
Anticancer Agents Med Chem. 2017;17(3):395-403
pubmed: 26902599
Anticancer Drugs. 2015 Jul;26(6):667-77
pubmed: 25811964
In Vivo. 2007 Nov-Dec;21(6):1003-9
pubmed: 18210747
ACS Med Chem Lett. 2022 Feb 18;13(3):499-506
pubmed: 35300078
Eur J Med Chem. 2013;70:723-39
pubmed: 24231308
Free Radic Res. 2007 Oct;41(10):1168-80
pubmed: 17886039